Published in:
Open Access
01-12-2022 | Herpes Virus | Research
Human herpesvirus 6 infection as a trigger of multiple sclerosis: an update of recent literature
Authors:
K. I. Voumvourakis, P.C. Fragkou, D. K. Kitsos, K. Foska, M. Chondrogianni, S. Tsiodras
Published in:
BMC Neurology
|
Issue 1/2022
Login to get access
Abstract
Background
This is an update on the existing evidence regarding a relationship between infection with human herpesvirus 6 (HHV-6) and multiple sclerosis (MS) in order to contribute on the attempt to define the nature and strength of that relationship.
Results
Study quality was assessed using the criteria proposed by Moore and Wolfson and by the classification criteria used by the Canadian Task Force on the Periodic Health Examination. Studies were categorized both by experimental technique and by quality (high [A], intermediate [B], and low [C]) as determined by the Moore and Wolfson criteria. Overall, 27 (90%) of 30 studies, 18 (86%) of which were classified as A quality, reached a statistically significant result. According to the Canadian Task Force classification, all studies were categorized as evidence of qualityII-1. Limitations of the available experimental techniques and perspectives for future research are discussed.
Conclusions
The current review continues to emphasize the need for further, objective, evidence-based examination of the relationship between HHV-6 infection and multiple sclerosis.